Business Context and Reporting Period
This Form 8-K, dated July 28, 2021, is filed by CleanTech Acquisition Corp. (not Nauticus Robotics, Inc., as indicated in the metadata request). The report details the consummation of the Company's Initial Public Offering (IPO) and related private placements. The Company is an emerging growth company incorporated in Delaware.
Key Financial Metrics
- Gross Proceeds from IPO: $150,000,000 from the sale of 15,000,000 Units at $10.00 per Unit.
- Gross Proceeds from Over-Allotment: $22,500,000 from the full exercise of the underwriters' option to purchase 2,250,000 additional Units.
- Private Placement Proceeds: $6,500,000 from the sale of 6,500,000 Private Warrants to initial stockholders.
- Additional Private Placement Proceeds: $675,000 from the sale of 675,000 additional Private Warrants concurrent with the over-allotment.
- Total Funds in Trust Account: $174,225,000 deposited as of July 28, 2021.
- Warrant Exercise Price: $11.50 per share.
Material Changes
The filing represents a material change in the Company's capital structure and liquidity status, transitioning from a pre-IPO entity to a public company with significant cash reserves held in trust. The full exercise of the over-allotment option increased the total number of Units sold by 15% compared to the initial offering.
Outlook and Management Commentary
The Company has established a trust account to hold proceeds for the benefit of public stockholders pending an initial business combination. An unaudited balance sheet reflecting these proceeds is included as Exhibit 99.1. The filing does not provide specific guidance on the timeline for a business combination or detailed risk factors beyond standard SPAC disclosures.
Investor Verification Checklist
- Verify the identity of the registrant as CleanTech Acquisition Corp. (CLAQ), noting the discrepancy with the requested company name (Nauticus Robotics, Inc.).
- Confirm the total amount held in the trust account ($174,225,000) against the unaudited balance sheet in Exhibit 99.1.
- Review the terms of the Private Warrants and the over-allotment option exercise to understand dilution implications.
- Check for subsequent filings regarding the selection of a target business combination.